SuperworthCigna Corporation CI
Medical - Healthcare Plans, Healthcare
$278.51
+1.51%
- Market cap
- $73.6B
- PE
- 11.5×
- 10y median 16.1×
- Forward PE
- Price to sales
- 0.3×
- EV/EBIT
- 9.7×
- Revenue, 12 months
- $282.4B
- +8% on a year ago
- Net margin
- 2.3%
- Free cash flow yield
- 12.4%
Cigna trades at 11.5× trailing earnings, cheaper than 88% of the last ten years. Revenue was $282.4B over the last twelve months, up 8% on a year earlier with a 2% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $51.1B | $57.3B | $60.5B | $63.7B | $65.6B+28% | $65.5B+14% | $67.2B+11% | $69.7B+10% | $72.5B+10% | $68.5B+5% | $71.7B+7% | |
| Cost of revenue | $35.3B | $41.4B | $44.5B | $47.6B | $49B+39% | $48.4B+17% | $53.3B+20% | $55.5B+17% | $57.8B+18% | $54.1B+12% | $56.7B+6% |
| Gross profit | $6.6B | $6.4B | $6.5B | $6.6B | $6.5B−2% | $6.6B+4% | $7.9B+21% | $5.9B−10% | $5.6B−14% | $6.5B−2% | $15B+90% |
| SG&A | $4.1B | $3.7B | $3.7B | $3.6B | $3.9B−5% | $4.2B+14% | $3.4B−7% | $3.4B−6% | $3.6B−7% | $3.7B−12% | $3.5B+1% |
| $2.1B | $2.3B | $2.4B | $2.6B | $2.2B+6% | $2B−13% | $2.3B−4% | $2.6B+0% | $2.3B+8% | $2.4B+20% | $2.7B+16% | |
| Interest expense | $360M | $322M | $375M | $376M | $362M+1% | $362M+12% | $337M−10% | $347M−8% | $335M−8% | $357M−1% | $356M+6% |
| Pre-tax income | $188M | $79M | $2B | $1.2B | $2B+969% | $1.6B+1986% | $2B+2% | $2.3B+93% | $1.8B−10% | $2.3B+38% | $2.3B+12% |
| −$919M | $291M | $360M | $367M | $473M | $239M−18% | $389M+8% | $322M−12% | $543M+15% | $409M+71% | $382M−2% | |
| Net income | $1.1B | −$212M | $1.6B | $825M | $1.5B+39% | $1.3B | $1.5B−6% | $1.9B+126% | $1.2B−20% | $1.7B+25% | $1.7B+8% |
| $3.49 | −$0.97 | $5.45 | $2.63 | $5.13+47% | $4.85 | $5.71+5% | $6.98+165% | $4.64−10% | $6.26+29% | $6.29+10% | |
| 294.6M | 286.5M | 284.1M | 281.4M | 277.8M−6% | 273M−5% | 268.2M−6% | 267.5M−5% | 265.9M−4% | 264M−3% | 264M−2% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Medical - Healthcare Plans within ten times Cigna's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CICigna Corporation | $73.6B | 11.5× | 16.1× | 0.3× | +8% | 2.3% | |
| ELVElevance Health Inc. | $87.7B | 18.0× | 17.6× | 0.4× | +6% | 2.5% | |
| CVSCVS Health Corp. | $112.5B | 23.3× | 16.2× | 0.3× | +7% | 1.2% | |
| HUMHumana Inc. | $47.6B | 37.5× | 20.5× | 0.3× | +18% | 0.9% | |
| UNHUnitedHealth Group Incorporated | $337.5B | 24.2× | 22.4× | 0.7× | +6% | 3.1% | |
| Peer median | $100.1B | 23.7× | 19.1× | 0.4× | +7% | 1.8% |
About
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .